Know2eat

Lutein

Isolated Compounds

What lutein may help with

Ranked by how strong the human evidence is — best supported first.

Best supportedMacular healthModerate evidence· 4 sources

Then, in order

About Lutein

A yellow xanthophyll carotenoid concentrated in the macula of the eye, extracted commercially from marigold flowers. It is one of only three carotenoids the human retina accumulates.

Lutein is the strongest evidence in the carotenoid category, and it comes from one very large, well-run trial programme. AREDS2 randomised more than four thousand people at risk of advanced age-related macular degeneration and, in its main comparison, substituted lutein and zeaxanthin for beta-carotene in the original AREDS formula; the ten-year follow-up reported lower progression to advanced disease with the lutein-containing formula, along with the finding that beta-carotene increased lung cancer risk in former smokers. That gives a defensible claim for macular health in people who already have intermediate AMD. It does not establish that lutein does anything for people with healthy eyes, which is who most lutein is sold to, and the blue-light and screen-fatigue marketing rests on far weaker studies.

Sold as
Softgel in oil, Capsule, Tablet, AREDS2-format eye formulas
Standardised to
Milligrams of free lutein; ester forms require hydrolysis in the gut and are labelled differently, which is a common source of dose confusion — a product without this marker may not resemble what was studied.
Also known as
FloraGLO lutein, Marigold lutein, Macular carotenoid

Regulation: Sold as a dietary supplement in the US with no pre-market efficacy review, though AREDS2-format eye supplements are widely recommended by ophthalmologists for a specific patient group. There is no authorised health claim for lutein and eye health in the EU.

What the research used

The amounts, forms and durations published trials of Lutein actually administered.

These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.

  • Studied for Age-related macular degeneration (AREDS2)

    10 mg

    Strong

    Lutein with 2 mg zeaxanthin, daily, within the AREDS2 formulation · 5 years, with 10-year follow-up

    This dose was studied inside a multi-nutrient formula containing vitamins C and E, zinc and copper, in people who already had intermediate macular degeneration. It is not evidence for lutein alone or for healthy eyes.

  • Studied for Macular pigment density in healthy adults

    6–20 mg

    Moderate

    Softgel, daily · 3–12 months

    Doses that raise macular pigment optical density measurably. That is a biomarker, and raising it in a healthy eye has not been shown to change vision or disease risk.

This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.

When it was taken

Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.

Each timing below was actually compared against an alternative in a trial, which is unusual.

  • With food

    Moderate

    Directly measured: lutein absorption rises substantially when it is taken with a fat-containing meal, and studies adding fat to a lutein-rich meal show several-fold differences in plasma response. This is one of the better-established food effects for any supplement.

    Timing was tested. A trial compared this window against another and reported a difference.

The evidence in depth

Best supported: Moderate

What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.

Macular health

Eye Health
Moderate evidence

In people with intermediate age-related macular degeneration, the AREDS2 formulation containing lutein and zeaxanthin was associated with slower progression to advanced disease, with the advantage over the beta-carotene formulation persisting at ten-year follow-up. This applies to a specific population already diagnosed with the condition, taking a specific multi-nutrient formula.

What may be going on: Lutein and zeaxanthin are selectively concentrated in the macula, where they absorb short-wavelength light and quench reactive oxygen species in a tissue with exceptionally high oxygen consumption.

Moderate evidence. Several human studies point the same way, with real caveats.

View the 4 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Visual function

Eye Health
Limited evidence

Trials report improvements in contrast sensitivity and glare recovery, and small studies suggest reduced eye strain during screen work. These are mostly small, short and inconsistent, and are a much weaker literature than the macular degeneration finding.

Limited evidence. Early human work, or mostly lab and animal research.

View the 3 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Cognitive function

Brain & Cognitive Health
Not enough evidence

Lutein accumulates in brain tissue and cross-sectional studies link higher macular pigment with better cognitive scores. Intervention trials are few and small, and no cognitive claim is supported.

Not enough evidence. Not enough human research to say anything useful yet.

View the 4 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Things to know

Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.

  • Worth knowing

    The evidence applies to people who already have macular degeneration

    AREDS2 enrolled people with intermediate AMD or advanced disease in one eye. It did not test whether lutein reduces the chance of developing macular degeneration in a healthy eye, and it is routinely marketed as though it did.

  • Worth knowing

    Do not substitute a beta-carotene formula if you have smoked

    The reason AREDS2 replaced beta-carotene with lutein is that beta-carotene increased lung cancer incidence in former smokers, consistent with two earlier large trials. Anyone with a smoking history should check that an eye formula contains lutein rather than beta-carotene.

  • Too much

    Carotenodermia and very high intakes

    High intakes can tint the skin yellow, which is harmless and fades after stopping. A case report describes crystalline deposits in the retina after prolonged very high lutein intake, which resolved on stopping.

  • Worth knowing

    Free lutein and lutein esters are not equivalent milligrams

    Marigold-derived lutein esters need to be hydrolysed before absorption and a given milligram figure delivers less free lutein. Labels are inconsistent about which is being declared, which makes dose comparison unreliable.

In the food catalogue

The whole-food form, where one exists. The evidence for a concentrated extract rarely transfers to the food, or the other way round — these are cross-links, not equivalents.

Egg yolkLower in absolute content than greens, but the lutein in egg yolk is…KaleOne of the densest dietary sources of lutein, alongside other dark…SpinachA major everyday source; absorption improves when eaten with fat.

Evidence ratings on this page: 1 moderate evidence, 1 limited evidence, 1 not enough evidence.

Supplements are sold in the US without pre-market review of efficacy or safety. Nothing on this page is a recommendation to take Lutein, or a dose to follow.